Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
19.80
-0.59 (-2.89%)
May 6, 2025, 4:00 PM EDT - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $970.29 million as of May 6, 2025. Its market cap has increased by 19.97% in one year.
Market Cap
970.29M
Enterprise Value
632.35M
1-Year Change
19.97%
Ranking
Category
Stock Price
$19.80
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has decreased from $974.02M to $970.29M, a decrease of -0.38%. That is a compound annual growth rate of -0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2025 | 964.90M | -12.23% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.45B |
| Johnson & Johnson | 372.94B |
| UnitedHealth Group | 368.47B |
| AbbVie | 346.84B |
| Novo Nordisk | 309.41B |
| Abbott Laboratories | 230.70B |
| AstraZeneca | 221.69B |
| Novartis AG | 221.37B |